Cosmetic outcome and surgical site infection rates of antibacterial absorbable (Polyglactin 910) suture compared to Chinese silk suture in breast cancer surgery: A randomized pilot research

Chinese Medical Journal

Volumn 124, Issue 5, 2011, Pages 719-724

  Zhang, Zhong Tao ^a   Zhang, Hong Wei ^b   Fang, Xue Dong ^c   Wang, Li Ming ^d   Li, Xiao Xi ^e   Li, Ya Fen ^f   Sun, Xiao Wei ^g   Carver, Judith ^h   Simpkins, Dorella ^h   Shen, Jessica ^h   Weisberg, Martin ^h  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

^d DALIAN MEDICAL UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g JOHNSON AND JOHNSON   (United States)

^h ETHICON INC   (United States)

Author keywords

Absorbable suture; Antibacterial; Cosmesis; Silk suture; Surgical site infection

Indexed keywords

POLYGLACTIN;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BREAST CANCER; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION RATE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; MATERIAL COATING; MULTICENTER STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SILK; SURGICAL INFECTION; SUTURE; VISUAL ANALOG SCALE; WOUND CLOSURE;

ANTI-BACTERIAL AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; POLYGLACTIN 910; SILK; SURGICAL WOUND INFECTION; SUTURES; TREATMENT OUTCOME;

EID: 79952530563     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.05.016     Document Type: Article

References (10)

1. Poandl TM. A 21-day exploratory pilot study comparing the cosmetic result of subcutuicular MONOCRYL Plus* versus transcutaneous Chinese silk for incisional wound closure in a pig model. Report, PSE Accession No. 07-0118, Project No. 67506, April 7, 2008.
2. Nandi PL, Soundara Rajan S, Mak KC, Chan SC, So YP. Surgical wound infection. Hong Kong Med J 1999; 5: 82-86.
3. Coello R, Glenister H, Fereres J, Bartlett C, Leigh D, Sedgwick J, et al. The cost of infection in surgical patients: a case-control study. J Hosp Infect 1993; 25:239-250.
4. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 2006; 203: 481-489.
5. Storch M, Perry LC, Davidson JM, Ward JJ. A 28-day study of the effect of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect (Larchmt) 2002; 3 (Suppl 1): S89-S98.
6. Gómez-Alonso A, García-Criado FJ, Parreño-Manchado FC, García-Sánchez JE, García-Sánchez E, Parreño-Manchado A, et al. Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. J Infect 2007; 54: 82-88.
7. Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 2007; 84: 232-236.
8. Hollander JE, Valentine SM, McCuskey CF, Turque T, Singer AJ. Long-term evaluation of cosmetic appearance of repaired lacerations: validation of telephone assessment. The Stony Brook Wound Registry Study Group. Ann Emerg Med 1998; 31: 92-98.
9. Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE. Development and validation of a novel scar evaluation scale. Plast Reconstr Surg 2007; 120: 1892-1897.
10. Hollander JE, Singer AJ, Valentine S, Henry MC. Wound registry: development and validation. Ann Emerg Med 1995; 25: 675-685.